{"celex_id": "32011D0810(01)", "uri": "http://publications.europa.eu/resource/cellar/9a9fefaf-a111-4c5b-be16-44e7e53a26cc", "type": "Decision", "concepts": ["3813", "5426", "5767", "8465"], "title": "Commission Decision of 9\u00a0August 2011 on appointing members of the Committee for Orphan Medicinal Products  Text with EEA relevance\n", "header": "10.8.2011 EN Official Journal of the European Union C 234/4\nCOMMISSION DECISION\nof 9 August 2011\non appointing members of the Committee for Orphan Medicinal Products\n(Text with EEA relevance)\n2011/C 234/06\nTHE EUROPEAN COMMISSION", "recitals": ",\nHaving regard to the Treaty on the Functioning of the European Union,\nHaving regard to Regulation (EC) No 141/2000 of the European Parliament and of the Council of 16 December 1999 on orphan medicinal products\u00a0(1), and in particular Article 4(3) thereof,\nHaving regard to the recommendation of the European Medicines Agency of 25 May 2011,\nWhereas:\n(1) The term of office of two members of the Committee for Orphan Medicinal Products which were appointed by the Commission on the recommendation from the European Medicines Agency expired in July 2011.\n(2) The European Medicines Agency has recommended the reappointment of these persons.\n(3) The members of the Committee shall be appointed for a period of three years starting on 1 September 2011,", "main_body": ["On the recommendation of the European Medicines Agency, the following are hereby reappointed members of the Committee for Orphan Medicinal Products for a term of three years from 1 September 2011:\nProf. J\u00e1nos BORVEND\u00c9G\nProf. Bruno SEPODES"], "attachments": "Done at Brussels, 9 August 2011.\nFor the Commission\nJohn DALLI\nMember of the Commission\n(1)\u00a0\u00a0OJ L 18, 22.1.2000, p. 1."}